Does Glycine Reduce Inflammation? What the Evidence Shows

When people talk about anti-inflammatory supplements, the usual suspects come up: omega-3s, curcumin, vitamin D, quercetin. Glycine almost never makes the list. That is partly because glycine is not exotic, partly because it is cheap, and partly because it sits at the intersection of amino acid chemistry and immunology in a way that does not fit neatly into the familiar supplement narrative. Yet for researchers who study macrophage biology and innate immunity, glycine has been a subject of genuine interest for more than two decades. The story of how a tiny amino acid might quiet inflammatory cells has some genuinely surprising biology behind it.

Why Glycine Is Unusual Among Amino Acids

Most amino acids are studied for their role in protein synthesis, but glycine does additional things that are relevant to inflammation. In the brain and spinal cord, glycine acts as an inhibitory neurotransmitter, working through glycine receptors that open chloride channels and reduce neural firing. This is well established neuroscience. What is less widely appreciated is that a version of this glycine-gated chloride channel also appears to exist on certain immune cells, including macrophages and neutrophils, the front-line responders of the innate immune system. When glycine binds to these channels on immune cells, it may hyperpolarize the cell membrane, blunting the calcium influx that is needed to trigger a full inflammatory response.

The proposed mechanism connects the chloride channel to the master switch of inflammation. Calcium influx into macrophages is one of the signals that activates NF-kB, the transcription factor that turns on genes for pro-inflammatory cytokines like TNF-alpha, IL-1beta, and IL-6. If glycine reduces calcium entry by opening chloride channels and shifting membrane potential, it could reduce NF-kB activation and the cytokine storm that follows. This mechanism was first described in detail by researchers at the University of North Carolina, who observed that glycine blunted NF-kB translocation into the nucleus of macrophages treated with lipopolysaccharide, a potent activator of inflammation. This chloride channel model remains a proposed mechanism rather than an established certainty, but it is biologically coherent and supported by multiple cell-based and animal studies.

Glycine also directly inhibits NF-kB activation by a second route. A 2021 review in Frontiers in Immunology and a comprehensive 2023 review in the International Journal of Molecular Sciences both describe evidence that glycine can prevent the degradation of IkB, the protein that normally keeps NF-kB inactive in the cytoplasm. When IkB is degraded, NF-kB is freed to enter the nucleus and activate inflammatory genes. When glycine keeps IkB stable, that inflammatory cascade is muted. These two pathways, the chloride channel route and the direct IkB stabilization route, may work together to give glycine its observed anti-inflammatory profile (Munoz-Islas et al., 2023).

What the Human Evidence Shows

The most cited human trial of glycine for inflammation was conducted in people with type 2 diabetes. In a randomized, double-blind, placebo-controlled study, researchers in Mexico gave participants either 5 grams of glycine per day or a matched placebo for three months and measured a range of metabolic and inflammatory markers. The glycine group showed a statistically significant reduction in TNF-receptor I levels compared with placebo, suggesting that glycine had meaningfully reduced activation of the TNF-alpha inflammatory pathway. Glycine also reduced hemoglobin A1c in that same trial, hinting at broader metabolic benefits. The authors concluded that glycine may decrease proinflammatory cytokine activity in people with metabolic disease (Cruz et al., 2008).

A smaller pilot trial in people with cystic fibrosis provided further, if limited, human data. A randomized, double-blind crossover trial published in BMC Pulmonary Medicine gave oral glycine at a dose of 0.5 grams per kilogram of body weight per day to children and adults with cystic fibrosis, a condition characterized by chronic airway inflammation, and compared outcomes to a placebo period of equal length. Serum TNF-alpha and sputum levels of IL-6 both trended downward during the glycine period, and lung function measured by FEV1 showed a numeric improvement. While the sample size was small and some of the inflammatory marker differences did not reach conventional statistical significance, the authors described the results as encouraging and called for larger studies (Vargas et al., 2017).

Cell-based research adds mechanistic credibility to the limited human trial data. A study in human coronary arterial endothelial cells found that glycine significantly reduced NF-kB activation, preserved levels of the protective protein IkBa, and lowered IL-6 production in cells stimulated with TNF-alpha. The authors reported that glycine, cysteine, and histidine all showed protective effects in this model, but glycine's effect was notable given that it is the simplest amino acid with no side chain. The implication was that glycine did not need any special chemical complexity to modulate the inflammatory machinery of endothelial cells (Lo et al., 2012).

The honest summary of the human evidence is that it is promising but still early. Large randomized controlled trials measuring high-sensitivity CRP as a primary outcome have not yet been published. The evidence that exists is mostly mechanistic or from small trials in specific disease populations. This is a different situation from, say, omega-3 fatty acids or selenium, where the human CRP literature is well developed. Anyone reading about glycine and inflammation should hold that picture accurately: the biology is compelling, the small trials point in the right direction, but the kind of evidence that would allow confident claims about CRP reduction in generally healthy people has not yet accumulated.

The Glycine Gap: Why Many People May Be Running Low

An important framing for thinking about glycine supplementation is the concept of a dietary glycine gap. The human body synthesizes some glycine on its own, mainly from serine, and also obtains it from dietary protein. However, several researchers have proposed that for a typical person eating a modern Western diet, endogenous synthesis plus dietary intake together may not fully meet the body's functional needs, particularly the needs of collagen production and the detoxification systems that rely on glycine. This potential shortfall does not mean deficiency in the clinical sense, but it may mean that intake is near the minimum rather than near the optimum.

The main reason for this gap is the shift away from connective tissue, bone broth, and organ meats in modern diets. Glycine is the most abundant amino acid in collagen, which is the primary protein in tendons, ligaments, skin, and bone. When people ate whole animals, including cartilaginous cuts, slow-cooked bones, and tougher connective tissue cuts, they obtained large amounts of glycine with every meal. Modern consumption patterns, focused on muscle meat, deliver the amino acids in muscle protein, which are relatively glycine-poor. A person eating only boneless skinless chicken breast and whey protein is obtaining amino acids in a very different ratio than someone eating ossobuco or beef tendon stew.

This matters for inflammation because glycine's roles in detoxification and glutathione synthesis are also metabolically relevant. Glycine is one of the three amino acids needed to synthesize glutathione, the body's master antioxidant, alongside cysteine and glutamate. Oxidative stress and inflammatory signaling are tightly coupled, so anything that limits glutathione production may indirectly permit more inflammation. This is a more indirect pathway than the chloride channel or NF-kB mechanism, but it adds another layer to why adequate glycine could matter for inflammatory tone over time.

Food Sources and Supplementation

Glycine is most abundant in foods derived from collagen-rich tissues. Bone broth and slow-cooked broths made from animal bones and cartilage are among the richest dietary sources, and this is the main reason bone broth has attracted wellness attention in recent years. Skin-on poultry, pork rinds, gelatin, and cuts that include tendons or cartilage, such as chicken feet or oxtail, are all comparatively high in glycine. Organ meats, particularly liver, also contain meaningful amounts. Among plant foods, legumes are the best source, though their glycine content per serving is considerably lower than collagen-rich animal foods.

Glycine supplements are widely available, typically as a white powder with a mildly sweet flavor. Common doses in research studies range from 3 grams to 5 grams per day, often taken in a single serving mixed into water or food. Glycine's slight sweetness, reminiscent of a mild sugar, makes it unusually palatable compared with most amino acid supplements. There is no established optimal dose for anti-inflammatory purposes, and doses used in human research vary by the condition being studied.

Glycine is considered extremely safe at supplemental doses commonly used in research. The body handles large amounts without trouble because glycine is a conditional non-essential amino acid that the body both synthesizes and readily metabolizes. Studies using doses up to 60 grams per day in acute settings for other conditions, including schizophrenia research, have generally found glycine to be well tolerated with few side effects. At the 3 to 5 gram per day doses most commonly discussed for general wellness, side effects are rare. Loose stools at high single doses have been reported but are not typical at moderate amounts.

Where Glycine Fits in the Bigger Picture

The most defensible framing of glycine is as a nutrient to ensure adequacy of, rather than a drug to take in megadoses for a specific effect. The evidence that correcting a dietary glycine gap improves inflammation-related outcomes in people with metabolic disease is real, if modest. The evidence that adding glycine on top of an already optimal diet provides measurable inflammatory benefits in healthy people is much weaker, largely because those trials have not been run yet.

Glycine fits naturally into broader dietary patterns that are themselves associated with lower inflammatory markers. A diet that includes bone broth, collagen-containing cuts of meat, and adequate protein overall is also a diet that tends to be less reliant on ultra-processed foods, refined sugars, and seed oils, all of which are associated with higher CRP. Separating the effect of glycine from the effect of a generally better diet is difficult in real-world populations, and this confounding is one reason the supplement literature has not grown as quickly as the basic science might suggest it should.

For people interested in monitoring their inflammatory status, the key point is that glycine is one contributor to overall inflammatory tone, not a standalone solution. The major drivers of CRP, body composition, sleep quality, physical activity, diet quality, smoking, and chronic stress, carry far more weight than any single micronutrient. But glycine represents an underappreciated piece of that broader puzzle, particularly for people whose diets skew toward muscle meats and away from the connective tissue cuts that were a staple of human diets for most of history. Because CRP is a general wellness marker and not a diagnostic test, any persistent elevation is worth discussing with a healthcare provider regardless of what dietary changes you are making.

Sources

• Munoz-Islas MA, Guajardo-Flores D, Jacobo-Velazquez DA. Glycine: The Smallest Anti-Inflammatory Micronutrient. International Journal of Molecular Sciences, 2023. pubmed.ncbi.nlm.nih.gov/37510995
• Cruz M, Maldonado-Bernal C, Mondragon-Gonzalez R, et al. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. Journal of Endocrinological Investigation, 2008. pubmed.ncbi.nlm.nih.gov/18852529
• Vargas MH, Del Razo-Juarez LI, Aguilar-Morales I, et al. Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial. BMC Pulmonary Medicine, 2017. pubmed.ncbi.nlm.nih.gov/29246256
• Lo HM, Hung CF, Tsai YJ, Wu BN, Chen CJ, Wu WB. Cysteine, histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells. Experimental Biology and Medicine, 2012. pubmed.ncbi.nlm.nih.gov/22236003
• Wheeler MD, Ikejema K, Enomoto N, et al. Glycine: a new anti-inflammatory immunonutrient. Cellular and Molecular Life Sciences, 1999. pubmed.ncbi.nlm.nih.gov/11212343

Frequently Asked Questions

Does glycine reduce inflammation?

Yes, with caveats. Glycine appears to suppress NF-kB, the master switch of inflammatory gene expression, and may dampen immune cell activity through a glycine-gated chloride channel on macrophages and neutrophils. A randomized trial in people with type 2 diabetes found that 5 grams per day of glycine for three months significantly reduced markers of TNF-alpha pathway activation. Large human trials specifically measuring CRP have not yet been published, so the evidence is promising but still early.

How much glycine should I take for inflammation?

Human trials on glycine and inflammation have used doses ranging from 3 to 5 grams per day. At these amounts, glycine is well tolerated by most people. There is no established optimal dose for anti-inflammatory purposes specifically, and any supplementation is best discussed with a healthcare provider, particularly if you have a chronic health condition.

What foods are highest in glycine?

Bone broth and slow-cooked broths made from animal bones are among the richest dietary sources, along with skin-on poultry, gelatin, pork rinds, and connective tissue cuts such as oxtail and chicken feet. Collagen supplements, which are derived from connective tissue, also deliver substantial glycine. Among plant foods, legumes are the best source, though at lower amounts per serving than animal-derived collagen sources.

Is glycine safe to supplement?

Glycine is considered very safe at the doses typically used in research. Studies have administered doses up to 60 grams per day in clinical settings without serious adverse effects, and the 3 to 5 gram per day amounts most commonly discussed for general wellness are well within a range considered safe for healthy adults. Glycine has a mildly sweet taste, which makes it more palatable than most amino acid supplements.